13例颅内恶性黑色素瘤的脑脊液临床特点分析

doi:10.3760/cma.j.issn.1007-1245.2023.24.028

国际医药卫生导报 ›› 2023, Vol. 29 ›› Issue (24): 3657-3660.DOI: 10.3760/cma.j.issn.1007-1245.2023.24.028

13例颅内恶性黑色素瘤的脑脊液临床特点分析

林裕¹ 许绍强¹ 成燕君² 时宏治¹

¹广东三九脑科医院检验科，广州　510510；²广东三九脑科医院神经内五科，广州　510510

收稿日期:2023-09-09 出版日期:2023-12-15 发布日期:2024-01-04
通讯作者: 许绍强，Email：15989148592@126.com

Clinical characteristics of cerebrospinal fluid in 13 cases of intracranial malignant melanoma

Lin Yu¹, Xu Shaoqiang¹, Cheng Yanjun², Shi Hongzhi¹

¹Department of Clinical Laboratory, Guangdong 999 Brain Hospital, Guangzhou 510510, China; ²Fifth Department of Neurology, Guangdong 999 Brain Hospital, Guangzhou 510510, China

Received:2023-09-09 Online:2023-12-15 Published:2024-01-04
Contact: Xu Shaoqiang, Email: 15989148592@126.com

摘要/Abstract

摘要：

目的　探讨颅内恶性黑色素瘤（intracranial malignant melanoma，IMM）患者的临床、影像学磁共振成像（magnetic resonance imaging，MRI）、脑脊液生化、脑脊液常规和细胞学的特点，提高对IMM的诊断能力。方法　回顾性分析2021年12月至2023年8月广东三九脑科医院收治的13例IMM患者的临床表现、影像学MRI、脑脊液生化、脑脊液常规和细胞学特点。结果　13例IMM患者中，脑脊液常规多数外观无色透明（62%，8例）或血性浑浊（15%，2例），蛋白阳性（54%，7例），有核细胞数正常（38%，5例）或轻度增高（62%，8例）；脑脊液细胞学可呈淋巴-单核细胞反应型（31%，4例）或混合细胞反应型（23%，3例），均找到黑色素肿瘤细胞（100%，13例）；脑脊液生化中多数蛋白（53%，7例）、乳酸脱氢酶（77%，10例）和乳酸（77%，10例）升高；常见症状有头痛（77%，10例）、头晕（38%，5例）、乏力（38%，5例）；MRI示脑膜有异常强化（92%，12例）。结论　IMM患者有一些脑脊液常规和细胞学、脑脊液生化、临床表现、MRI表现的特点，能给临床医师提供帮助，特别是在脑脊液找到黑色素肿瘤细胞对诊断有重大意义，病理诊断可最终确诊。

关键词:

颅内恶性黑色素瘤, 脑脊液生化, 脑脊液细胞学, 颅内转移

Abstract:

Objective　To investigate the clinical, imaging, magnetic resonance imaging (MRI), cerebrospinal fluid biochemistry, routine, and cytological features of patients with intracranial malignant melanoma (IMM), and to improve the diagnostic ability of IMM. Methods　The clinical manifestations and imaging MRI, cerebrospinal fluid biochemical, routine, and cytological characteristics of 13 patients with IMM admitted to Guangdong 999 Brain Hospital from December 2021 to August 2023 were retrospectively analyzed. Results　Among the 13 patients, the cerebrospinal fluid was colorless and transparent in 8 cases (62%), was muddy in 2 cases (15%), and was protein-positive in 7 cases (54%); the number of nucleated cells was normal in 5 cases (38%), and was slightly increased in 8 cases (62%); the cerebrospinal fluid cytology was lympho-monocyte response type in 4 cases (31%), and was mixed cell response type in 3 cases (23%); melanoma cells were found in all the 13 cases (100%). The cerebrospinal fluid biochemistry showed that the protein increased in 7 cases (53%), lactate dehydrogenase increased in 10 cases (77%), and lactic acid increased in 10 cases (77%). The common symptoms were headache (77%, 10 cases), dizziness (38%, 5 cases), and fatigue (38%, 5 cases). MRI showed abnormal enhancement of meninges (92%, 12 cases). Conclusion　IMM has some characteristics of cerebrospinal fluid routine and cytology, cerebrospinal fluid biochemistry, clinical manifestations, and MRI manifestations, which can provide clinicians with great help. Especially, finding melanoma cells in cerebrospinal fluid is of great significance for diagnosis, and pathological diagnosis can confirm the final diagnosis.

Key words:

Intracranial malignant melanoma, Cerebrospinal fluid biochemistry, Cerebrospinal fluid cytology, Intracranial metastasis

林裕许绍强成燕君时宏治.

13例颅内恶性黑色素瘤的脑脊液临床特点分析 [J]. 国际医药卫生导报, 2023, 29(24): 3657-3660.

Lin Yu, Xu Shaoqiang, Cheng Yanjun, Shi Hongzhi.

Clinical characteristics of cerebrospinal fluid in 13 cases of intracranial malignant melanoma [J]. International Medicine and Health Guidance News, 2023, 29(24): 3657-3660.

参考文献

[1] 编写组中国黑色素瘤规范化病理诊断专家共识年版. 中国黑色素瘤规范化病理诊断专家共识(2017年版)[J]. 中华病理学杂志, 2018,47(1):7-13. DOI: 10.3760/cma.j.issn.0529-5807.2018.01.003.
[2] 陈利锋, 韩丽娜, 刘嘉霖, 等. 中枢神经系统原发恶性黑色素瘤临床分析[J]. 临床神经外科杂志, 2020,17(5):528-532. DOI: 10.3969/j.issn.1672-7770.2020.05.010.
[3] Simonsen TG, Gaustad JV, Rofstad EK. Bevacizumab treatment of meningeal melanoma metastases[J]. J Transl Med, 2020,18(1): 13. DOI: 10.1186/s12967-020-02212-3.
[4] 张海霞, 李磊, 金磊, 等. 云南省肿瘤医院1 203例黑色素瘤临床分析[J]. 昆明医科大学学报, 2022, 43(8): 56-60. DOI: 10.12259/j.issn.2095-610X.S20220808.
[5] 尹如娇, 解玥, 凌冰冰, 等. 12例中枢神经系统原发恶性黑色素瘤的影像学表现[J]. 重庆医学, 2017, 46(32): 4584-4586. DOI: 10.3969/j.issn.1671-8348.2017.32.038.
[6] Arai N, Kagami H, Mine Y, et al. Primary solitary intracranial malignant melanoma: a systematic review of literature[J]. World Neurosurg, 2018, 117: 386-393. DOI: 10.1016/j.wneu.2018.06.138.
[7] 刘俊杰, 汪卫建, 周彦汝, 等. 颅内恶性黑色素瘤的影像学特点分析[J]. 中国实用神经疾病杂志, 2021, 24(17): 1506-1515. DOI: 10.12083/SYSJ.2021.14.033.
[8] 韩雨璇, 吴鹏, 杨超. 颅内不典型黑色素瘤一例[J]. 磁共振成像, 2020,11(11):1032-1033. DOI: 10.12015/issn.1674-8034.2020.11.015.
[9] Ma J, Zhang Z, Li S, et al. Intracranial amelanotic melanoma: a case report with literature review [J]. World J Surg Oncol, 2015,13:182. DOI: 10.1186/s12957-015-0600-z.
[10] 赵邦凤, 张艳琼, 徐迅. 恶性黑色素瘤伴胸腔积液1例报告[J]. 国际医药卫生导报, 2022, 28(10):1442-1444. DOI: 10.3760/cma.j.issn.1007-1245.2022.10.028.
[11] 高巍, 付永娟, 岳娉, 等. 颅内黑色素细胞病变的临床病理分析及文献复习[J]. 北京医学, 2016,38(5):400-404.
[12] 许绍强. 脑脊液细胞学图谱及临床诊断思路[M]. 北京: 人民卫生出版社, 2021.
[13] 朱红敏, 吴革菲, 邵剑波, 等. 儿童原发性脑膜黑色素瘤1例[J]. 中华实用儿科临床杂志, 2019,34(23):1823-1825. DOI: 10.3760/cma.j.issn.2095-428X.2019.23.016.
[14] 孙连杰, 王琳洁, 杨小朋. 颅内原发性恶性黑色素瘤的诊治进展[J]. 中国临床神经外科杂志, 2020,25(4):251-253. DOI: 10.13798/j.issn.1009-153X.2020.04.021.
[15] 焦贺男, 闫东明. 原发性和继发性颅内恶性黑色素瘤临床特征及预后分析[J]. 中国现代医生, 2022,60(17):19-23, 225.
[16] 陈述. 恶性黑色素瘤的靶向药物治疗进展[J]. 现代医药卫生, 2022,38(7):1184-1188. DOI: 10.3969/j.issn.1009-5519.2022.07.023.
[17] Rishi A, Yu HM. Current treatment of melanoma brain metastasis[J]. Curr Treat Options Oncol, 2020,21(6):45. DOI: 10.1007/s11864-020-00733-z.
[18] 董永, 孙季萍, 楼芳. 恶性黑色素瘤脑转移的综合治疗进展[J]. 临床肿瘤学杂志, 2019,24(10):948-953.

13例颅内恶性黑色素瘤的脑脊液临床特点分析

Clinical characteristics of cerebrospinal fluid in 13 cases of intracranial malignant melanoma

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics